WASHINGTON, Aug. 9, 2018 /PRNewswire/ — 60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of Arakoda (tafenoquine) tablets for the prevention of malaria in patients aged 18 years and older. For…Original Article
FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
